EOI: Driving equitable access to fit-for-purpose antigen-detecting rapid diagnostic tests for COVID-19

July 9th, 2020

Published: July 9th, 2020

EOI closes July 24, 2020 – Unitaid and FIND are calling for expressions of interest (EOI) to accelerate the availability and manufacturing scale-up of rapid diagnostic tests for the detection of SARS-CoV-2 antigens.

This EOI is has been prepared in the context of the Access to COVID-19 Tools (ACT) Accelerator Diagnostics Pillar. Launched by FIND and Unitaid, it supports the work plans of two working groups within the pillar: “R&D of tests & digital tools” (led by the Bill & Melinda Gates Foundation and the Praesens Foundation) and “Market readiness” (led by Unitaid and FIND).

Innovators, RDT developers, IVD manufacturers and LMIC-based diagnostic stakeholders are invited to apply.

A range of funding mechanisms could be applied according to the needs of each business case.

More information on the EOI, including how to apply, can be found here.